Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine.
about
Folding efficiency is rate-limiting in dopamine D4 receptor biogenesisOculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.C-terminus glycans with critical functional role in the maturation of secretory glycoproteins.Comparative evaluation of diode laser ablation and surgical stripping technique for gingival depigmentation: A clinical and immunohistochemical study.Different approaches for assaying melanosome transferComparison of surgical stripping; erbium-doped:yttrium, aluminum, and garnet laser; and carbon dioxide laser techniques for gingival depigmentation: a clinical and histologic study.Genes and pathways downstream of telomerase in melanoma metastasisL-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functionsAncillary role of vitamin C in pink aestheticsDeep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targetsGlycosphingolipids are required for sorting melanosomal proteins in the Golgi complex.Tyrosinase maturation through the mammalian secretory pathway: bringing color to life.Chemical and pharmacological chaperones as new therapeutic agents.Klotho regulates retinal pigment epithelial functions and protects against oxidative stress.Synthesis and preliminary in vitro biological evaluation of 5-chloro-2-(substituted phenyl)benzo[d]thiazole derivatives designed as novel antimelanogenesis agents.Pharmacological folding chaperones act as allosteric ligands of Frizzled4.Melanoma cells present high levels of HLA-A2-tyrosinase in association with instability and aberrant intracellular processing of tyrosinase.Pink-eyed dilution protein controls the processing of tyrosinase.Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturationp53 prevents progression of nevi to melanoma predominantly through cell cycle regulationInfluence of N-glycan processing disruption on tyrosinase and melanin synthesis in HM3KO melanoma cells.Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells.Down-regulation of melanin synthesis by a biphenyl derivative and its mechanism.Pheomelanin coat colour dilution in French cattle breeds is not correlated with the TYR, TYRP1 and DCT transcription levels.Association of lip pigmentation with smoking and gingival melanin pigmentation.Conformation-dependent post-translational glycosylation of tyrosinase. Requirement of a specific interaction involving the CuB metal binding site.The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells.Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes.Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease.D-tyrosine negatively regulates melanin synthesis by competitively inhibiting tyrosinase activity.Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
P2860
Q24297696-3CE2059D-6623-4D5F-A71C-283D5F7DA867Q30394454-B6428204-BE65-438B-9F8C-D670123154E1Q31015215-5F497127-FC01-4F26-919A-A60434757C97Q33662404-5BAE995A-0E67-4C14-8337-97D1E70CC5EEQ34333872-693C74F1-E448-4BBF-B36C-5A10D1A5256EQ34419597-E6531BAB-176E-43B4-931E-6010971AA037Q34983978-6B8AA5AD-C918-4623-95B5-A7E9F943A90CQ35624374-1048C407-C4DB-456C-B268-66B26BCB0676Q35698604-7197DFBB-6DD3-44F6-95D0-1C0FEF46E4E2Q36270042-848FD82C-AC56-413E-B7BC-3CEEEC99C93FQ36294101-80B88C33-197A-4BAB-ACB8-573672107909Q36371592-F2418CA9-3E40-45CB-95BB-0DFAE320CAD0Q36863386-2CA01584-49FC-4B63-B833-DB15560DE386Q37261449-8108732E-39BC-4F21-8E12-741BBE7522E2Q38458527-2B9E5F6A-D561-427F-A933-B14BA2463F1BQ38902274-2E2F9565-4C41-4258-83EE-4F1B11F9EEBBQ39359227-FE4B2DAA-4C4C-4FF2-81AC-B2CDBA21D77EQ39617200-E4CA00CD-1B04-437E-85B9-7150AF3D0D4AQ39646963-BC26323D-F51E-4CF4-9903-6BCD2AE2FFB8Q39654655-22BC9D30-5B73-466A-B071-CBB2F2A7BD79Q40183434-586F04EE-9914-4A90-8C8C-7F6EE8CB073DQ40536392-627EBDA6-E3D7-4F81-80DF-028D31EF85F1Q40638684-9016681F-63D2-478C-8CDC-87F5A714C737Q42631348-C9BD0B9C-C2AF-4197-92F7-E5E823831183Q43999684-39ABD19D-D2E9-4A27-B999-6E2307F666C1Q44321502-CE45A58D-3D20-4D3A-865F-728A86D70732Q44635555-F5D2DDB1-FAA6-4E8A-B11A-1D055EA5A489Q44666427-3DEBB6BE-DAF5-492B-8652-AC9D26B8CE2AQ44724684-30D6FFC3-6464-44D8-916E-4BEFB4B348FCQ46386596-2082D890-46E1-4119-83BB-893638007681Q47624921-0652FBF9-3788-4214-91B2-7DF2B0BB8E88Q50014672-F72C97E0-D6D2-471C-BDE3-6AAB05145823
P2860
Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@ast
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@en
type
label
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@ast
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@en
prefLabel
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@ast
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@en
P2093
P2860
P356
P1476
Proper folding and endoplasmic ...... substrates, DOPA and tyrosine.
@en
P2093
P2860
P304
11933-11938
P356
10.1074/JBC.M008703200
P407
P577
2000-12-20T00:00:00Z